Rosiglitazone Improves Glucocorticoid Resistance in a Sudden Sensorineural Hearing Loss by Promoting MAP Kinase Phosphatase-1 Expression

Notoginsenoside Fc attenuates high glucose-induced vascular endothelial cell injury via upregulation of PPAR-γ in diabetic Sprague–Dawley rats

(2018) Jingjing Liu et al.   VASCULAR PHARMACOLOGY

Aminophylline restores glucocorticoid sensitivity in a guinea pig model of sudden sensorineural hearing loss induced by lipopolysaccharide

(2017) Qiong-Qiong Zhou et al.   Scientific Reports

Rosiglitazone protects rat liver against acute liver injury associated with the NF-κB signaling pathway

(2016) Wei Chen et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease

(2016) Zhilong Jiang et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

MKP-1 attenuates LPS-induced blood-testis barrier dysfunction and inflammatory response through p38 and IκBα pathways

(2016) Yiqing Pan et al.   Oncotarget

Heterogeneity in mechanisms influencing glucocorticoid sensitivity: The need for a systems biology approach to treatment of glucocorticoid-resistant inflammation

(2015) Christine R. Keenan et al.   PHARMACOLOGY & THERAPEUTICS

Effects of PPAR-γ Agonist Treatment on LPS-Induced Mastitis in Rats

(2014) Ding Mingfeng et al.   INFLAMMATION

A case-control study on proinflammatory genetic Polymorphisms on sudden sensorineural hearing loss

(2014) Gabriella Cadoni et al.   LARYNGOSCOPE

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Proinflammatory cytokine IL-1 β polymorphisms in sudden sensorineural hearing loss

(2012) Jae-Young Um et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Correlations of Inflammatory Biomarkers With the Onset and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss

(2012) Masatsugu Masuda et al.   OTOLOGY & NEUROTOLOGY

DUSPs, to MAP kinases and beyond

(2012) Ching-Yu Huang et al.   Cell and Bioscience

p38 Mitogen-Activated Protein Kinase Pathways in Asthma and COPD

(2011) Kian Fan Chung   CHEST

Dynamic regulation of glucocorticoid signalling in health and disease

(2011) S. C. Biddie et al.   RHEUMATOLOGY

The investigation of Mitogen-Activated Protein kinase Phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging

(2010) Cheng-Jeng Tai et al.   BMC CANCER

Induction of glucocorticoid receptor-β expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines

(2010) A. Vazquez-Tello et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Potential Therapeutic Targets for Steroid-Resistant Asthma

(2010) Wan Wang et al.   CURRENT DRUG TARGETS

Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells

(2009) Hsun-Jin Jan et al.   CANCER LETTERS

Regulation of the RelA (p65) transactivation domain

(2008) John M. O'shea et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms

(2008) Jae-Hyuk Yi et al.   BRAIN RESEARCH

The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats

(2008) Servet Kavak et al.   CELL BIOCHEMISTRY AND FUNCTION

Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

(2008) P Bhavsar et al.   THORAX